SEC Tracker
Get the app

Possible new APVO shares

APVODilution

Last raise Oct 30, 2026, 424B5: 303K shares (16.8% of the 1.8M then) at $1.34, $406K gross

Known so far: no new shares from the prospectus covers read · shelf room about $2.9M · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $2.9M
  • One third of float $3.3M ($9.8M float, Jun 30, 2025)
  • Room grows Oct 30, 2027
How this is worked out

Shelf room about $2.9M on the S-3 of Feb 14, 2025: the baby-shelf rule (public float under $75M) caps sales at one third of the $9.8M public float stated as of Jun 30, 2025, $3.3M, less $406K sold off it in the last 12 months (424B5 Oct 30, 2026 $406K); it grows again from Oct 30, 2027, 12 months after the first sale counted. Sources: S-3 Feb 14, 2025, effective Feb 26, 2025 · public float, as of Jun 30, 2025 · 424B5 Oct 30, 2026.

What could become new Aptevo Therapeutics (APVO) shares, from its 10-Q, 10-K, S-1 or 424B filings.

Read so far: the cover share count (1.8M shares, +887% from 183K on Aug 11, 2025, adjusted for the 1-for-18 reverse split by Mar 26, 2026). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-1 registration filings.

Shares outstanding

1.8M

Nov 2024 to Aug 2026: from 1.4K to 1.8M. Adjusted for three reverse splits, 1-for-37 by Feb 14, 2025, 1-for-20 by Aug 11, 2025 and 1-for-18 by Mar 26, 2026: each earlier count is divided by the ratio of every split after it.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.